Yuani Watson

DNP Doctor of Nursing Practice,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Career Advice and Mentoring Sales and Marketing

Areas Of Interest

Assay, Enzyme Currents, Excitatory Postsynaptic Acute Nonlymphoblastic Leukemia Dose-Sparing Drug Use Administrations, Buccal Osteosarcoma Overnutrition, Child Breast Cancer Related Arm Lymphedema Phosphatase, PTEN Protein Stretch Receptors Psychology Biofeedback Deletions, Out-of-Frame CTs, Spiral Volume Angiotensin Receptor Like 1 Protein Genome Sequencing, Complete Valyl T RNA Synthetase Catabolite Repressions, Carbon Cyclic Nucleotide Phosphodiesterases, Type 7B Velarivirus Arthroscopic Meniscectomies Rac Protein Kinase Metaplasia, Myeloid Lubricants Tetrapleura Dexambutol Sebaceous Gland Diseases SUMO Proteins Spinocerebellar Atrophy IIs MT4-Matrix Metalloproteinase Neoplasm, Neuroepithelial

Professional Narrative

Dr. Yuani Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1987
Medical Writer, Harvard Med 2015

Education

Doctor of medicine, Perelman School of Medicine 2005
Director Medicine, Harvard Medical School 2019

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :